Researcher
Marc BUYSE
- Keywords:Mathematics
- Disciplines:Other mathematical sciences and statistics not elsewhere classified
Affiliations
- Data Science Institute (Research institute)
Member
From1 Jun 2019 → Today - Mathematics and statistics (Department)
Member
From1 Jan 2013 → Today - Centre for Statistics (Research group)
Member
From1 Jan 1994 → Today - Faculty of Sciences (Faculty)
Member
From1 Oct 1991 → Today - Applied Mathematics (Department)
Member
From1 Oct 2001 → 31 Dec 2012 - Research Institute Center for Statistics (Research institute)
Member
From1 Oct 1994 → 31 May 2019 - Mathematics-Physics-Informatics (Division)
Member
From1 Oct 1991 → 30 Sep 2009
Publications
1 - 10 of 109
- Minimization in randomized clinical trials(2023)
Authors: Elisabeth Coart, Perrine Bamps, Emmanuel Quinaux, Geneviève Sturbois, Everardo D Saad, Tomasz BURZYKOWSKI, Marc BUYSE
Pages: 5285 - 5311 - HIGHLIGHTING THE MULTIDIMENSIONAL BENEFITS OF A DRUG USING GENERALIZED PAIRWISE COMPARISONS(2023)
Authors: J. C. Chiem, E. Saad, M. De Backer, S. Salvaggio, S. Kosta, E. Barre, Vaiva DELTUVAITE-THOMAS, Johan VERBEECK, Marc BUYSE
Pages: S19 - Trial Design for Cancer Immunotherapy: A Methodological Toolkit(2023)
Authors: Everardo D. Saad, Elisabeth Coart, Vaiva DELTUVAITE-THOMAS, Leandro GARCIA BARRADO, Tomasz BURZYKOWSKI, Marc BUYSE
- Generalized pairwise comparisons for censored data: An overview(2023)
Authors: Vaiva DELTUVAITE-THOMAS, Johan VERBEECK, Tomasz BURZYKOWSKI, Marc BUYSE, Christophe Tournigand, Geert MOLENBERGHS, Olivier THAS
- Individualized Net Benefit estimation and meta-analysis using generalized pairwise comparisons in N-of-1 trials(2023)
Authors: Joris Giai, Julien Peron, Matthieu Roustit, Jean-Luc Cracowski, Pascal Roy, Brice Ozenne, Marc BUYSE, Delphine Maucort-Boulch
- Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week(2023)
Authors: Johan VERBEECK, Mickael De Backer, Jan VERWERFT, Samuel Salvaggio, Marco Valgimigli, Pascal VRANCKX, Marc BUYSE, Edgar Brunner
Pages: 1360 - 1372 - Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Rece...(2023)
Authors: Pierre D. Squifflet, Everardo Saad, Sibylle T. Loibl, Marion van Mackelenbergh, Michael Untch, Priya Rastogi, Luca Gianni, Andreas Schneeweiss, Pierfranco Conte, Martine Piccart, et al.
Pages: 2988 - + - Disease-free survival as the endpoint in multimodal rectal cancer trials: have we got this right?(2023)
Authors: Emmanouil Fokas, Claus Roedel, J. Joshua Smith, Julio Garcia-Aguilar, Marc BUYSE, Robert Glynne-Jones
Pages: 962 - 964 - INCLUDING PATIENT RELEVANT ENDPOINTS (QUALITY OF LIFE) IN MULTICOMPONENT ENDPOINTS WITH GENERALIZED PAIRWISE COMPARISONS(2023)
Authors: Johan VERBEECK, Backer M. De, E. Barre, S. Salvaggio, Vaiva DELTUVAITE-THOMAS, J. C. Chiem, S. Kosta, Marc BUYSE
Pages: S335 - Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scores(2023)
Authors: Vaiva DELTUVAITE-THOMAS, Mickael De Backer, Samantha Parker, Marie Deneux, Lynda E. Polgreen, Cara O'Neill, Samuel Salvaggio, Marc BUYSE